Evidence map›Paper›PMID 31323249›Full record

ArticleThe Journal of infection2019

Comparative global epidemiology of influenza, respiratory syncytial and parainfluenza viruses, 2010-2015.

Tommy T Lam, Julian W Tang, Florence Y Lai, Hassan Zaraket, Ghassan Dbaibo, Seweryn Bialasiewicz, Sarah Tozer, Jean-Michel Heraud, Steven J Drews, Todd Hachette and 21 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infection, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors.

Tommy T LamState Key Laboratory of Emerging Infectious Diseases, School of Public Health, The University of Hong Kong, Hong Kong SAR, China.
Julian W TangClinical Microbiology, University Hospitals Leicester, Level 5 Sandringham Building, Leicester Royal Infirmary, Infirmary Square, Leicester LE1 5WW, UK. Electronic address: julian.tang@uhl-tr.nhs.uk.
Florence Y LaiCardiovascular Biomedical Research Unit, University of Leicester, Leicester, UK.
Hassan ZaraketFaculty of Medicine, American University of Beirut, Beirut, Lebanon.
Ghassan DbaiboFaculty of Medicine, American University of Beirut, Beirut, Lebanon.
Seweryn BialasiewiczChild Health Research Centre, The University of Queensland, Brisbane, Australia; Children's Health Queensland, Brisbane, Australia.
Sarah TozerChild Health Research Centre, The University of Queensland, Brisbane, Australia; Children's Health Queensland, Brisbane, Australia.
Jean-Michel HeraudNational Influenza Center, Virology Unit, Institut Pasteur de Madagascar, Antananarivo 101, Madagascar.
Steven J DrewsAlberta Provincial Laboratory for Public Health, University of Alberta, Edmonton, AB, Canada.
Todd HachetteDepartment of Pathology, Dalhousie University, Halifax, NS, Canada.
Paul Ks ChanDepartment of Microbiology, The Chinese University of Hong Kong SAR, Hong Kong, China.
Evelyn Sc KoayDepartment of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Hong Kai LeeMolecular Diagnosis Centre, National University Hospital, Singapore.
Kok Keng TeeFaculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Yang LiuState Key Laboratory of Emerging Infectious Diseases, School of Public Health, The University of Hong Kong, Hong Kong SAR, China.
Pieter LA FraaijDepartment of Pediatrics, Erasmus Medical Centre, Rotterdam, Netherlands; ViroScience, Erasmus Medical Centre, Rotterdam, Netherlands.
Lance JenningsPathology Department, University of Otago, Christchurch, New Zealand.
Matti WarisInstitute of Biomedicine, University of Turku, Finland; Clinical Microbiology, Turku University Hospital, Turku, Finland.
Mel KrajdenBritish Columbia Centre for Disease Prevention and Control, Vancouver, BC, Canada.
André CorriveauGovernment of the Northwest Territories, Yellowknife, NT, Canada.
Hamid JalalDepartment of Pathology, Addenbrookes Hospital, Cambridge, UK.
Hidekazu NishimuraVirus Research Center, Sendai Medical Center, Sendai, Japan.
Pagbajabyn NymadawaLaboratory of Virology, National Center for Communicable Diseases, Ulaanbaatar, Mongolia.
Darmaa BadarchLaboratory of Virology, National Center for Communicable Diseases, Ulaanbaatar, Mongolia.
Aripuana WatanabeDepartment of Parasitology, Microbiology and Immunology, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
Alice KabandaNational Reference Laboratory, Kigali, Rwanda.
Theo SlootsChild Health Research Centre, The University of Queensland, Brisbane, Australia; Children's Health Queensland, Brisbane, Australia.
Jen KokNSWHP-ICPMR, Westmead Hospital, Sydney, Australia; Pathology and Infectious Diseases, University of Sydney, Sydney, Australia.
Dominic E DwyerNSWHP-ICPMR, Westmead Hospital, Sydney, Australia; Pathology and Infectious Diseases, University of Sydney, Sydney, Australia.
Marion KoopmansViroScience, Erasmus Medical Centre, Rotterdam, Netherlands.
INSPIRE (International Network for the Sequencing of Respiratory Viruses)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo improve our understanding of the global epidemiology of common respiratory viruses by analysing their contemporaneous incidence at multiple sites.

methods2010-2015 incidence data for influenza A (IAV), influenza B (IBV), respiratory syncytial (RSV) and parainfluenza (PIV) virus infections were collected from 18 sites (14 countries), consisting of local (n = 6), regional (n = 9) and national (n = 3) laboratories using molecular diagnostic methods. Each site submitted monthly virus incidence data, together with details of their patient populations tested and diagnostic assays used.

resultsFor the Northern Hemisphere temperate countries, the IAV, IBV and RSV incidence peaks were 2-6 months out of phase with those in the Southern Hemisphere, with IAV having a sharp out-of-phase difference at 6 months, whereas IBV and RSV showed more variable out-of-phase differences of 2-6 months. The tropical sites Singapore and Kuala Lumpur showed fluctuating incidence of these viruses throughout the year, whereas subtropical sites such as Hong Kong, Brisbane and Sydney showed distinctive biannual peaks for IAV but not for RSV and PIV.

conclusionsThere was a notable pattern of synchrony of IAV, IBV and RSV incidence peaks globally, and within countries with multiple sampling sites (Canada, UK, Australia), despite significant distances between these sites.

Indexed as

AfricaAsia, SoutheasternAustralasiaEuropeHumansInfluenza A virusInfluenza B virusInfluenza, HumanMiddle EastMolecular Diagnostic TechniquesNorth AmericaParamyxoviridae InfectionsRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsRespirovirusSeasonsEpidemiologyGlobalIncidenceInfluenza virusParainfluenza virusRespiratory syncytial virusSeasonality

Identifiers

PMID31323249
PMCPMC7112594

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.